Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring

Abstract COVID-19 is an infection induced by the SARS-CoV-2 coronavirus, and severe forms can lead to acute respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) management. Severe forms are associated with coagulation changes, mainly characterized by an increase in D-dimer and fi...

Full description

Bibliographic Details
Main Authors: Sophie Susen, Charles Ambroise Tacquard, Alexandre Godon, Alexandre Mansour, Delphine Garrigue, Philippe Nguyen, Anne Godier, Sophie Testa, Jerrold H. Levy, Pierre Albaladejo, Yves Gruel, on behalf of GIHP and GFHT
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Critical Care
Subjects:
COVID-19
Thrombosis
Obesity
Anticoagulant
Heparin
Coagulation
Online Access:http://link.springer.com/article/10.1186/s13054-020-03000-7

Internet

http://link.springer.com/article/10.1186/s13054-020-03000-7

Similar Items